Cardiologia

OMS: mais de 700 milhões de pessoas com hipertensão não tratada – Número de pessoas hipertensas dobrou para 1,28 bilhões desde 1990.

26 Ago, 2021 | 12:27h

More than 700 million people with untreated hypertension – World Health Organization

Estudo original: Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.

Comentário no Twitter (fio – clique para saber mais)

The number of adults aged 30-79 living with #hypertension has doubled from 650 million to 1.28 billion since 1990, according to a 🆕 comprehensive global 🌎🌍🌏 analysis of trends in hypertension prevalence, detection, treatment and control.

👉 https://t.co/MI48CX2kEO pic.twitter.com/ARpS8uipeY

— World Health Organization (WHO) (@WHO) August 25, 2021

Diretrizes de consenso com recomendações para atividade física em idosos.

26 Ago, 2021 | 12:25h

International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines – The journal of nutrition, health & aging

M-A de estudos randomizados | Efetividade da manobra de Valsalva (MV) modificada em adultos com taquicardia supraventricular (TSV) – “A metanálise mostrou uma taxa significativamente maior de conversão para ritmo sinusal com MV modificada em comparação à MV padrão em pacientes com TSV (odds ratio = 4,36; 95% intervalo de confiança, 3.30–5.76; P < 0.001).”

26 Ago, 2021 | 12:24h

Effectiveness of the modified Valsalva manoeuvre in adults with supraventricular tachycardia: a systematic review and meta-analysis – European Journal of Emergency Medicine (link para o resumo – $ para o texto completo)

Conteúdo relacionado: Randomized Trial: Standard Valsalva vs. Modified Valsalva for Cardioversion of SVT (estudos e comentários sobre o tema)

Vídeo: Modified Valsalva manoeuvre for supraventricular tachycardia – The Lancet

Comentário de estudo | Sem elogios para reserva fracionada de fluxo do miocárdio (FFR) no estudo FLOWER-MI.

26 Ago, 2021 | 12:18h

No blossom for fractional flow reserve in FLOWER-MI – European Heart Journal

Estudo original: #ACC21 – RCT: In patients with STEMI undergoing complete revascularization, an FFR-guided strategy did not improve outcomes compared to an angiography-guided strategy.

Análise de especialista | Dose ideal de aspirina para a prevenção secundária em pacientes com doença cardiovascular aterosclerótica (DCVA) – “Uma estratégia de aspirina em baixa dose é melhor para a maioria dos pacientes com DCVA dada a efetividade similar, menor risco de sangramento e melhor adesão geral.”

26 Ago, 2021 | 12:17h

Ideal Aspirin Dose for Secondary Prevention in Patients With ASCVD – American College of Cardiology

Conteúdo relacionado: #ACC21 – RCT: No significant differences in cardiovascular events or major bleeding between patients receiving 81 mg vs. 325 mg of aspirin daily.

Tópicos principais em coração do atleta do ACC Care of the Athletic Heart 2021 Virtual.

26 Ago, 2021 | 12:16h

Top Pearls from ACC Care of the Athletic Heart 2021 Virtual – American College of Cardiology

Conteúdos relacionados:

20-year observational study suggests return to play is manageable for most athletes with Long QT Syndrome or genetic heart diseases.

#ESCCongress – ESC Position statement: Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease

Brazilian Guidelines for Sports and Exercise Cardiology

Canadian Position Statement on the Cardiovascular Screening of Competitive Athletes

Position Statement: Recommendations for Participation in Competitive and Leisure Time Sport in Athletes with Cardiomyopathies, Myocarditis, and Pericarditis

The Female Athlete’s Heart: Facts and Fallacies

Position Statement: Recommendations for Participation in Competitive Sports of Athletes with Arterial Hypertension

Expert Analysis: The Heart of the Female Athlete

Research: Sudden Cardiac Arrest during Participation in Competitive Sports

Tendências mundiais na prevalência de hipertensão e progresso no tratamento e no controle entre 1990 e 2019: uma análise agrupada de 1.201 estudos de representatividade populacional com 104 milhões de participantes.

25 Ago, 2021 | 13:14h

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants – The Lancet

Comentário: Global and national high blood pressure burden and control – The Lancet (necessário cadastro gratuito)

Comentário no Twitter

Our new analysis within #NCDRisC on the #worldwide #hypertension #prevalence in last 30 yrs published in @TheLancet. The number of people with HTN doubled from 1990 with 626 million🕴️‍♀️ and 652 million 🕴️ in 2019. Control rates were ⬇️10% in some countries!https://t.co/FdjusD38X3 pic.twitter.com/famYphfqC8

— Maciej Banach (@maciejbanach) August 25, 2021

Estudo randomizado | Ablação suprarrenal baseada em cateter reduz o aldosteronismo primário.

25 Ago, 2021 | 13:07h

Catheter-Based Adrenal Ablation Remits Primary Aldosteronism: A Randomized Medication-Controlled Trial – Circulation (gratuito por tempo limitado)

Comentário no Twitter

#ResearchLetter: RCT data show catheter-based adrenal ablation effectively ⬇️ BP in primary aldosteronism comparable to spironolactone – A potential therapy for patients unable to tolerate medications? https://t.co/ImSAdnVtxE #AHAJournals pic.twitter.com/WSJjFpzKPo

— Circulation (@CircAHA) August 21, 2021

Guia para estatísticas e métodos: interpretação do sistema de classificação de recomendações da ACC/AHA.

25 Ago, 2021 | 13:03h

Interpreting the ACC/AHA Clinical Practice Guideline Recommendation Classification System – JAMA (gratuito por tempo limitado)

Revisão | Ablação com criobalão como tratamento inicial da fibrilação atrial.

25 Ago, 2021 | 12:53h

Cryoballoon Ablation as Initial Treatment for Atrial Fibrillation: JACC State-of-the-Art Review – Journal of the American College of Cardiology

Conteúdos relacionados:

Subgroup analysis of RCT suggests early rhythm control therapy is beneficial for patients with atrial fibrillation and heart failure.

Meta-Analysis: Catheter Ablation Improves Outcomes in Patients with Atrial Fibrillation Complicated with Heart Failure

Catheter Ablation for Atrial Fibrillation Improves Outcomes in Heart Failure with Reduced Ejection Fraction

M-A: In patients with atrial fibrillation, catheter ablation was associated with a 38% reduction in recurrence and a 68% reduction in hospitalizations. The rate of serious complications was 4.2% with ablation vs. 2.8% in the antiarrhythmic group, a difference that was not statistically significant.

CABANATrial: Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation